Ixchiq - direct healthcare professional communication (DHPC)

Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Ixchiq (Chikungunya vaccine (live)): new contraindication in patients aged 65 years and older while EU-wide review is ongoing

Dissemination date: 22/05/2025

Key facts

• Medicine name:
  Ixchiq
• Active substance:
  Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
• Therapeutic area (MeSH):
  Chikungunya virus
• Procedure number:
  EMEA/H/A-20/1540
• Regulatory outcome:
  Variation
• DHPC type:
  Adverse event
• Dissemination date:
  22/05/2025